We are facing an unprecedented time with the challenges of the COVID-19 pandemic. This global emergency has raised many difficult questions, such as how to: identify who is infectious, determine who may need what levels of hospital care, discover modifiable risk factors, determine best predict prognosis, establish best practices for ethical resource allocation, and determine which drugs are viable for specific patient cohorts, and many others.
Cochrane provides high-quality, relevant, and up-to-date synthesized research evidence to inform health decisions. This page highlights content relating to the coronavirus (COVID-19) pandemic and the various related activities that Cochrane is undertaking in response.
In response to the coronavirus pandemic, the ASA has established an online community, COVID-19 Data, Statistics, Research, and Discussion. This is a place for members to share their work, post resources, make new connections, and discuss questions related to COVID-19 research.
Conducting trials of novel interventions during infectious disease emergencies, such as the ongoing Covid-19 pandemic, is increasingly recognized as important for determining the efficacy of potential vaccines and therapies. Clinical trials to evaluate investigational interventions are being implemented as part of the broader efforts to control the spread of an infectious disease and to improve patient outcomes. In such circumstances, however, it can be challenging to acquire the necessary evidence about the effects of the interventions to inform future patient care and public health planning, in part because of the unpredictable size, geographic location, and duration of outbreaks.
Randomized clinical trials provide the highest-quality evidence for identifying therapies to help people attain longer and healthier lives...
Researchers across the University of Oxford are at the forefront of global efforts to understand the coronavirus (COVID-19) and protect our communities.
What Physicians Need to Know During the COVID-19 pandemic, many physicians are working from home, using their personal computers and mobile devices to help care for patients. Fortunately, technology can allow physicians and care teams to do much of what they could do at the medical office, remotely. Telemedicine is a powerful tool that spans a continuum of technologies and offers new ways to deliver care. Many electronic health record (EHR) systems allow you to connect over the Internet just as if you were in the clinic. While you are doing your part to help during the COVID-19 pandemic, the American Medical Association (AMA) and American Hospital Association (AHA) want to ensure you have resources to help keep your work environment safe from cyber-threats that could disrupt your practice, the hospital, or negatively impact your patients’ safety and well-being.